Bill number does not exist. Enter a vaild keyword.

Committee Testimony and Witness Signup

HB0615 - Workgroup on Black, Latino, Asian American Pacific Islander, and Other Underrepresented Behavioral Health Professionals - Extension of Dates

Health and Government Operations 2/16/2023 1:00:00 PM
Finance 3/22/2023 1:00:00 PM
As of: 5/23/2024 11:27:59 PM
Name Organization Position Testimony Committee
Delegate Amprey, Delegate Amprey FAV In Person - Oral Testimony
HGO
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - 2023 HB 615 FAV - Workforce Workgroup E HGO
Lee, Mickey UNF No Testimony HGO
mcavoy, vince UNF No Testimony HGO
Schulze, Dana USAF Veteran UNF No Testimony HGO
D’Orazio , Daniela UNF No Testimony HGO
MANOHAR, KRISHNA UNF No Testimony HGO
Vernon, Michael UNF No Testimony HGO
Arneson, Emily Kennedy Krieger Institute FAV HB615_BHDiversityWorkforce_KennedyKrieger_Support. HGO
Hessler, Therese FAV No Testimony HGO
brenner, loretta UNF No Testimony HGO
Krone, Christine FAV No Testimony HGO
Kolakoski, Virginia UNF No Testimony HGO
Williams, Peggy UNF No Testimony HGO
Elbourn, James UNF No Testimony HGO
Ditraglia, Frank UNF No Testimony HGO
Lang, Beverly Nurse Practitioner Association of Maryland FWA HB615 LOS Workgroup- Underrepesented Behavioral He HGO
Diefenbach, Linda UNF No Testimony HGO
Amprey, Marlon FAV In Person - Oral Testimony
HB615 Written Testimony.pdf
HGO
Katz, Janet UNF No Testimony HGO
oga, Maryland Department of Health /Office of Governmen Maryland Dept. of Health FAV 10 - HB 615 - HGO - MDH - LOS.pdf HGO
Lang, Alan UNF No Testimony HGO
Arshavsky, Svetlana UNF No Testimony HGO
Delegate Amprey, Delegate Amprey FAV In Person - Oral Testimony
FIN
Rosen-Cohen, Nancy NCADD-Maryland FAV NCADD-MD - 2023 HB 615 FAV - Workforce Workgroup E FIN
Krone, Christine FAV No Testimony FIN
Tompsett, Thomas Harris Jones & Malone FAV HB 615 - Support - MPS WPS.pdf FIN
Peters, Sarah Husch Blackwell Strategies FAV No Testimony FIN
(MD), State of Maryland FAV 9 - HB 615 (3rd) - FIN - MDH - LOS.docx.pdf FIN
Testimony, All N/A Merged Testimony as of 3-21-2023 at 344 PM FIN
Click to return on the top page